Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver diseaseErina Kumagai, Tatsuya Kanto, Yohei Mano et al.|Scientific Reports|2016Cited by 105
Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver diseaseHirotaka Shoji, Tatsuya Kanto, Sachiyo Yoshio et al.|Scientific Reports|2016Cited by 64
Effects of In-Hospital Exercise on Frailty in Patients with Hepatocellular CarcinomaJin Tsuchihashi, Takuji Torimura, Shunji Koya et al.|Cancers|2021Cited by 40
Myostatin as a fibroblast‐activating factor impacts on postoperative outcome in patients with hepatocellular carcinomaSachiyo Yoshio, Tatsuya Kanto, Ryuki Hashida et al.|Hepatology Research|2021Cited by 31
Effects of a low‐intensity resistance exercise program on serum miR‐630, miR‐5703, and Fractalkine/CX3CL1 expressions in subjects with No exercise habits: A preliminary studyRyuki Hashida, Naoto Shiba, Hiroo Matsuse et al.|Hepatology Research|2021Cited by 29